# Ginkgo Bioworks

Type: Company (DNA)

Source: Startup Intelligence Brief — https://getstartupbrief.com/entity/ginkgo-bioworks
Canonical HTML page: https://getstartupbrief.com/entity/ginkgo-bioworks

## Timeline

- **2026-02-27**: Strategic Pivot Confirmed — Company details divestiture of biosecurity and focus on autonomous laboratory offerings.
- **2026-02-26**: Earnings Release — Ginkgo reports Q4 and full-year 2025 results, revealing a $0.38 EPS beat.
- **2026-02-25**: Pre-Earnings Analysis — Market analysts provide insights into upcoming Q4 2025 expectations for Ginkgo Bioworks.

## Recent coverage (1 stories)

### Ginkgo Bioworks Beats EPS by $0.38, Pivots to AI-Driven Autonomous Labs
2026-02-27 03:43:48 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Ginkgo Bioworks surpassed Q4 2025 earnings expectations with a significant $0.38 EPS beat, signaling a major strategic shift. The company is divesting its biosecurity business to focus exclusively on AI-integrated autonomous laboratory services.
Full story: https://getstartupbrief.com/story/ginkgo-bioworks-q4-2025-earnings-pivot-autonomous-labs

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getstartupbrief.com/guides/methodology for the full editorial methodology.